Cochlear implantation in psoriasis patients

Basavaraj, Sreeshyla; Wardrop, Peter; Sivaji, N.; Shanks, Mary; Allen, Agnes

doi:10.1016/j.anl.2006.07.004

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, promising advances have been performed in the treatment of immune-mediated inner ear disease with various TNF-α inhibitors (etanercept, infliximab, golimumab; as used in other underlying autoimmune diseases or as form of local intratimpanic infusion), demonstrating them to be effective in reducing inflammation and hearing loss in cochlear diseases [44,51]. Nonetheless, if hearing loss still occurs, cochlear implantation is a safe and effective method for the auditory rehabilitation of severe SNHL [44,52]. However, flap complications are more common in cases such as psoriasis, where the risk of surgical site infection is higher than normal patients.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Audiovestibular Dysfunction and Hearing Loss in Patients with Psoriasis and Psoriatic Arthritis

Akarsu¹

2020

An Overview and Management of Multiple Chronic Conditions

View full text Add to dashboard Cite

Psoriasis is now considered a T cell-mediated chronic systemic inflammatory disease rather than only a simple skin disease. The relationship and coexistence of this common disease with many other comorbidities have gained increasing attention in recent years. Although psoriatic skin lesions are seen frequently in the auricle and external auditory canal, there are not many studies evaluating the possible effect of psoriatic disease (psoriasis with or without joint involvement) on the auditory system. Hearing impairment detected in psoriasis patients is mostly seen as subclinical hearing loss at high frequencies, but it can also have a significant impact on patients' health and quality of life due to the possible risk of developing sudden sensorineural hearing loss. In this chapter, the frequency, pattern, and patient-related risk factors of hearing impairment and audiovestibular dysfunction in patients with psoriasis and psoriatic arthritis were extensively reviewed and discussed. In conclusion, it was emphasized that subclinical sensorineural hearing loss is a neglected but an important comorbidity in patients with psoriasis and psoriatic arthritis. The relationship between psoriatic disease and audiovestibular dysfunction supports the need for further studies aimed at better identification of the underlying pathogenic mechanisms, and accordingly to update diagnostic and even treatment approaches.

show abstract

Section: Discussionmentioning

confidence: 99%

“…However, flap complications are more common in cases such as psoriasis, where the risk of surgical site infection is higher than normal patients. It has been beneficial to add perioperative antipsoriatic topical agents and/or UVB phototherapy to standard infection prophylaxis in terms of reducing postoperative infection and sequelae [52].…”

Section: Discussionmentioning

confidence: 99%